⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21787375 | 0.76 | KDM4E (0.30) | — | |
| SCHEMBL21787382 | 0.76 | KDM4E (0.30) | — | |
| SCHEMBL21787373 | 0.72 | CSNK2A1 (0.30) | — | |
| SCHEMBL21787383 | 0.72 | KDM4E (0.30) | — | |
| SCHEMBL21787387 | 0.69 | MAPT (0.33) | — | |
| SCHEMBL21787371 | 0.65 | — | — | |
| SCHEMBL21787384 | 0.65 | — | — | |
| SCHEMBL21787167 | 0.65 | — | — | |
| SCHEMBL21787376 | 0.62 | — | — | |
| SCHEMBL13715652 | 0.58 | GLS (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11180493-B2 | SGC stimulators | CYCLERION THERAPEUTICS, INC. (US) | 2021-11-23 | — | — | US | disclosed |
| US-20200071318-A1 | SGC STIMULATORS | TISENTO THERAPEUTICS INC. | 2020-03-05 | — | — | US | disclosed |